Sunday, October 25, 2026Daily EditionIndependent journalism
BeCrypto NewsIndependent digital asset reporting
Sign in Write
BTC $80,549 +0.21%ETH $2,344.57 +0.23%SOL $101.75 +0.37%XRP $1.30 +0.54%BNB $741.65 +1.16%DOGE $0.0773 +0.18%Prices: CoinGecko,
Back
Markets

AstraZeneca Says Experimental Stomach Cancer Drug Doubled Survival

By John Kim for TokenPost

Image: TokenPost

The company identified sonesitatug vedotin as the experimental treatment in a late-stage study.

Read the full story on TokenPost

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.

Latest in Markets

All Markets stories